The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Ventricular Remodeling

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ventricular Remodeling


High impact information on Ventricular Remodeling


Chemical compound and disease context of Ventricular Remodeling


Biological context of Ventricular Remodeling


Anatomical context of Ventricular Remodeling


Associations of Ventricular Remodeling with chemical compounds


Gene context of Ventricular Remodeling


Analytical, diagnostic and therapeutic context of Ventricular Remodeling


  1. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K., Komuro, I. Nat. Med. (2005) [Pubmed]
  2. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. Nguyen, Q.T., Cernacek, P., Calderoni, A., Stewart, D.J., Picard, P., Sirois, P., White, M., Rouleau, J.L. Circulation (1998) [Pubmed]
  3. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. Levine, H.J., Gaasch, W.H. J. Am. Coll. Cardiol. (1996) [Pubmed]
  4. Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Grishko, V., Pastukh, V., Solodushko, V., Gillespie, M., Azuma, J., Schaffer, S. Am. J. Physiol. Heart Circ. Physiol. (2003) [Pubmed]
  5. Overview of the treatment of heart failure. Cohn, J.N. Am. J. Cardiol. (1997) [Pubmed]
  6. Ventricular remodeling: hype or hope? McCarthy, P.M. Nat. Med. (1996) [Pubmed]
  7. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Pfeffer, J.M., Fischer, T.A., Pfeffer, M.A. Annu. Rev. Physiol. (1995) [Pubmed]
  8. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Yamaguchi, O., Higuchi, Y., Hirotani, S., Kashiwase, K., Nakayama, H., Hikoso, S., Takeda, T., Watanabe, T., Asahi, M., Taniike, M., Matsumura, Y., Tsujimoto, I., Hongo, K., Kusakari, Y., Kurihara, S., Nishida, K., Ichijo, H., Hori, M., Otsu, K. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  9. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Wollert, K.C., Studer, R., Doerfer, K., Schieffer, E., Holubarsch, C., Just, H., Drexler, H. Circulation (1997) [Pubmed]
  10. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. St John Sutton, M., Pfeffer, M.A., Moye, L., Plappert, T., Rouleau, J.L., Lamas, G., Rouleau, J., Parker, J.O., Arnold, M.O., Sussex, B., Braunwald, E. Circulation (1997) [Pubmed]
  11. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Jugdutt, B.I., Khan, M.I., Jugdutt, S.J., Blinston, G.E. Circulation (1995) [Pubmed]
  12. Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction. Jugdutt, B.I., Khan, M.I. Circulation (1994) [Pubmed]
  13. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. Hayashi, M., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Tsutsui, T., Matsui, T., Fujii, M., Matsumoto, T., Yamamoto, T., Horie, H., Ohnishi, M., Kinoshita, M. J. Am. Coll. Cardiol. (2001) [Pubmed]
  14. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. Nahrendorf, M., Hu, K., Hiller, K.H., Galuppo, P., Fraccarollo, D., Schweizer, G., Haase, A., Ertl, G., Bauer, W.R., Bauersachs, J. J. Am. Coll. Cardiol. (2002) [Pubmed]
  15. Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen. Jugdutt, B.I., Khan, M.I., Jugdutt, S.J., Blinston, G.E. J. Am. Coll. Cardiol. (1995) [Pubmed]
  16. Survival after myocardial infarction in rats: captopril versus losartan. Milavetz, J.J., Raya, T.E., Johnson, C.S., Morkin, E., Goldman, S. J. Am. Coll. Cardiol. (1996) [Pubmed]
  17. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats. Shimada, T., Yoshiyama, M., Takeuchi, K., Omura, T., Takemoto, Y., Kim, S., Iwao, H., Yoshikawa, J. Cardiovasc. Res. (1998) [Pubmed]
  18. beta2-Adrenergic Stimulation Attenuates Left Ventricular Remodeling, Decreases Apoptosis, and Improves Calcium Homeostasis in a Rodent Model of Ischemic Cardiomyopathy. Xydas, S., Kherani, A.R., Chang, J.S., Klotz, S., Hay, I., Mutrie, C.J., Moss, G.W., Gu, A., Schulman, A.R., Gao, D., Hu, D., Wu, E.X., Wei, C., Oz, M.C., Wang, J. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  19. Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats. Yoshiyama, M., Omura, T., Takeuchi, K., Kim, S., Shimada, K., Yamagishi, H., Teragaki, M., Akioka, K., Iwao, H., Yoshikawa, J. J. Mol. Cell. Cardiol. (2001) [Pubmed]
  20. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Kitzmueller, E., Vécsei, A., Pichler, J., Böhm, M., Müller, T., Vargha, R., Csaicsich, D., Aufricht, C. Pediatr. Nephrol. (2004) [Pubmed]
  21. Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. Melillo, G., Lima, J.A., Judd, R.M., Goldschmidt-Clermont, P.J., Silverman, H.S. Circulation (1996) [Pubmed]
  22. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Iwasaka, T., Takahashi, N., Nakamura, S., Sugiura, T., Tarumi, N., Kimura, Y., Okubo, N., Taniguchi, H., Matsui, Y., Inada, M. Diabetes Care (1992) [Pubmed]
  23. Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction. Frantz, S., Hu, K., Widder, J., Bayer, B., Witzel, C.C., Schmidt, I., Galuppo, P., Strotmann, J., Ertl, G., Bauersachs, J. Br. J. Pharmacol. (2004) [Pubmed]
  24. Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. Chancey, A.L., Gardner, J.D., Murray, D.B., Brower, G.L., Janicki, J.S. Am. J. Physiol. Heart Circ. Physiol. (2005) [Pubmed]
  25. Effects of enalapril on T and B cell function in rats after myocardial infarction. Waltman, T.J., Harris, T.J., Cesario, D., Ziegler, M., Maisel, A.S. J. Card. Fail. (1995) [Pubmed]
  26. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. McDonald, K.M., Garr, M., Carlyle, P.F., Francis, G.S., Hauer, K., Hunter, D.W., Parish, T., Stillman, A., Cohn, J.N. Circulation (1994) [Pubmed]
  27. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. Pouleur, H., Rousseau, M.F., van Eyll, C., Stoleru, L., Hayashida, W., Udelson, J.A., Dolan, N., Kinan, D., Gallagher, P., Ahn, S. Circulation (1993) [Pubmed]
  28. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Teerlink, J.R., Pfeffer, J.M., Pfeffer, M.A. Circ. Res. (1994) [Pubmed]
  29. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Doughty, R.N., Whalley, G.A., Gamble, G., MacMahon, S., Sharpe, N. J. Am. Coll. Cardiol. (1997) [Pubmed]
  30. Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. McDonald, K.M., Francis, G.S., Matthews, J., Hunter, D., Cohn, J.N. J. Am. Coll. Cardiol. (1993) [Pubmed]
  31. Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling. Voros, S., Yang, Z., Bove, C.M., Gilson, W.D., Epstein, F.H., French, B.A., Berr, S.S., Bishop, S.P., Conaway, M.R., Matsubara, H., Carey, R.M., Kramer, C.M. Am. J. Physiol. Heart Circ. Physiol. (2006) [Pubmed]
  32. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling. Miki, T., Miura, T., Yano, T., Takahashi, A., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Nishihara, M., Naitoh, K., Ohori, K., Shimamoto, K. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  33. Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Malavazos, A.E., Cereda, E., Morricone, L., Coman, C., Corsi, M.M., Ambrosi, B. Eur. J. Endocrinol. (2005) [Pubmed]
  34. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction. Matsunaga, T., Abe, N., Kameda, K., Hagii, J., Fujita, N., Onodera, H., Kamata, T., Ishizaka, H., Hanada, H., Osanai, T., Okumura, K. International journal of cardiology. (2005) [Pubmed]
  35. Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction. Soeki, T., Tamura, Y., Shinohara, H., Sakabe, K., Onose, Y., Fukuda, N. Circ. J. (2002) [Pubmed]
  36. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Kaikita, K., Hayasaki, T., Okuma, T., Kuziel, W.A., Ogawa, H., Takeya, M. Am. J. Pathol. (2004) [Pubmed]
  37. Role of endothelin-1 in myocardial failure. Sam, F., Colucci, W.S. Proc. Assoc. Am. Physicians (1999) [Pubmed]
  38. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Tallant, E.A., Ferrario, C.M., Gallagher, P.E. Am. J. Physiol. Heart Circ. Physiol. (2005) [Pubmed]
  39. Effects of captopril therapy after late reperfusion on left ventricular remodeling after experimental myocardial infarction. Jain, P., Korlipara, G., Mallavarapu, C., Sikand, V., Lillis, O., Cohn, P.F. Am. Heart J. (1994) [Pubmed]
  40. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? Schinkel, A.F., Poldermans, D., Rizzello, V., Vanoverschelde, J.L., Elhendy, A., Boersma, E., Roelandt, J.R., Bax, J.J. J. Thorac. Cardiovasc. Surg. (2004) [Pubmed]
WikiGenes - Universities